3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 25856201 | Design of Coltuximab Ravtansine, a CD19-Targeting Antibody-Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure-Activity Relationships and Preclinical Evaluation. | 2015 Jun 1 | 2 |
2 | 24023523 | Targeting CD19 in B-cell lymphoma: emerging role of SAR3419. | 2013 | 2 |
3 | 22003072 | SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies. | 2011 Oct 15 | 1 |